Page last updated: 2024-08-24

etofibrate and Hyperlipemia

etofibrate has been researched along with Hyperlipemia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19904 (40.00)18.7374
1990's4 (40.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dietlein, M; Geiss, HC; Parhofer, KG1
Lang, PD; Vollmar, J1
Füsgen, I; Summa, JD1
Krüger, B1
Wolf, HR1
dos Santos, JE; Loures-Vale, AA; Martinez, TL; Novazzi, JP; Rabelo, LM1
Chelstowski, K; Jastrzebska, M; Kopciewicz, J; Naruszewicz, M; Pieczul-Mróz, J; Torbus-Lisiecka, B1
Coelho, OR; Mansur, AP; Maranhão, RC; Ramires, JA; Rodrigues-Sobrinho, CR; Sposito, AC1
Catalán, RE; Maroto, ML; Piña, M; Priego, JG1
Pfeiffer, M; Tilsner, V1

Trials

6 trial(s) available for etofibrate and Hyperlipemia

ArticleYear
Influence of etofibrate on LDL-subtype distribution in patients with diabetic dyslipoproteinemia.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2003, Volume: 111, Issue:6

    Topics: Adult; Aged; Body Mass Index; Cholesterol; Cholesterol, HDL; Clofibric Acid; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Triglycerides

2003
[An alternative in the therapy of primary hyperlipemias: etofibrate in depot preparations].
    Medizinische Klinik, 1980, Nov-07, Volume: 75, Issue:23

    Topics: Adolescent; Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides

1980
Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Drugs under experimental and clinical research, 1994, Volume: 20, Issue:3

    Topics: Cholesterol; Cholesterol, HDL; Clofibric Acid; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Single-Blind Method; Triglycerides

1994
[Evaluation of efficacy and safety of etofibrate in primary hyperlipidemia. A multicenter study].
    Arquivos brasileiros de cardiologia, 1996, Volume: 67, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholesterol; Clofibric Acid; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Triglycerides

1996
Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome.
    International journal of clinical pharmacology research, 1999, Volume: 19, Issue:1

    Topics: Arteriosclerosis; Clofibric Acid; Diabetes Mellitus, Type 1; Factor VII; Fibrinogen; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pilot Projects; Risk Factors; Statistics, Nonparametric

1999
Etofibrate but not controlled-release niacin decreases LDL cholesterol and lipoprotein (a) in type IIb dyslipidemic subjects.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2001, Volume: 34, Issue:2

    Topics: Analysis of Variance; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibric Acid; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoprotein(a); Male; Middle Aged; Niacin; Statistics, Nonparametric; Triglycerides

2001

Other Studies

4 other study(ies) available for etofibrate and Hyperlipemia

ArticleYear
[Bezafibrate and delayed action etofibrate in hyperlipidemia].
    Deutsche medizinische Wochenschrift (1946), 1983, Feb-25, Volume: 108, Issue:8

    Topics: Bezafibrate; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Triglycerides

1983
Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
    International journal of clinical pharmacology research, 1994, Volume: 14, Issue:5-6

    Topics: Adult; Aged; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibric Acid; Drug Synergism; Drug Therapy, Combination; Female; Fibrinogen; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoprotein(a); Male; Middle Aged; Practice Guidelines as Topic; Triglycerides

1994
Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats.
    General pharmacology, 1979, Volume: 10, Issue:4

    Topics: Animals; Clofibrate; Clofibric Acid; Diet; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Liver; Male; Nicotinic Acids; Rats; Triglycerides

1979
[Influence of etofibrate on plasmaviscosity in hyperlipoproteinemias (author's transl)].
    Medizinische Klinik, 1978, Jan-13, Volume: 73, Issue:2

    Topics: Blood Viscosity; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides

1978